Last reviewed · How we verify
NCT07188298
Risk Factors and Clinical Outcomes of Neonatal Anemia in NICU
trial in Hemolytic Disease of Newborn in 40 participants. Not yet recruiting.
25 August 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 25 October 2025 |
| Primary completion | 25 August 2026 |
| Estimated completion | 1 November 2026 |
Conditions studied
- Hemolytic Disease of Newborn — all drugs for Hemolytic Disease of Newborn →
- Anemia of Neonates — all drugs for Anemia of Neonates →
- Sepsis — all drugs for Sepsis →
Sponsor
Assiut University
Who can join
Adults 1 Day to 30 Days, any sex, with Hemolytic Disease of Newborn or Anemia of Neonates. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Risk Factors, and Clinical Outcomes of Neonatal Anemia in the NICU of a Tertiary Care Hospital
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07188298
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemolytic Disease of Newborn
Currently open trials in the same condition.
- NCT04218318 — Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07188298 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07188298.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing